AMSbiopharma is an analytical CRO devoted to providing Bioanalytical and CMC services for the Life Science industry throughout the entire product life cycle, from Research & Development to Product Manufacturing and Commercialization.

We provide services to clients worldwide in the pharmaceutical, biopharmaceutical, biotechnology, fine chemistry, medical cannabis, cosmeceutical and nutraceutical industries.

Things that make us a reliable and top quality CMC service provider:

- Our laboratory works under GLP/GMP following the latest EMA and FDA guidelines. Additionally we possess ISO certification such as 9001 & 140001

- We cover a broad spectrum of target molecules: Small molecules, Nitrosamines, Biomolecules (Hormones, Cannabinoids, Aminoacids, Peptides, Proteins, mABs, ADCs, Plasmids, Oligonucleotides), Heavy Metals, and many more depending on the clients' needs.

- We can do fully-customizable analytical studies related to: Vaccines, HCPs, Cell&Gene Therapies, Extractables & Leachables, Residuals Testing, Peptide Mapping, Metabolomics, Proteomics and In-vitro/In-vivo testing. We support stability studies as well.

- One of our biggest strength relies on our direct-to-expert approach and fast response time: up to 7 days after sample arrival for Routine QC validated methods, and up to 2 months for Method Development and Validation.

Tell us about your current challenges and ongoing projects. We can help you make it through.

We Looking forward to seeing you at the event

As a Global Science Provider, AnaPath specializes in high end histopathology and preclinical services, designed to support biotech and pharma companies seeking robust, expert driven development pathways. Our mission is to provide the scientific depth and personalized attention that innovative programs require.
AnaPath operates through two complementary European sites:
• Liestal, Switzerland – Our pathology institute and center of excellence for specialized scientific advice. With seven board certified pathologists, we deliver primary histopathology readouts, peer reviews, histomorphometry, immunofluorescence, RNAscope, microCT, laser microdissection, SEM/EDX, TEM, and more—covering early discovery up to fully regulatory studies.
• Barcelona, Spain – A GLP certified, AAALAC accredited facility equipped for high capacity study execution under strict OECD compliance. Our teams run studies across rodents, dogs, minipigs, and NHP, and provide comprehensive bioanalytical support for biologics, NCEs, and biomarkers throughout preclinical and clinical phases.
Our vision is to act as your long term scientific partner. We fly higher by providing deep pathology expertise tailored to complex programs such as medical devices, toxicology, and ATMPs.

Anapharm Bioanalytics is a bioanalytical CRO supporting pharmaceutical and biotechnology companies across preclinical and clinical development (Phase I–III).

We provide high-quality, regulatory-compliant bioanalysis for both small and large molecules, including LC-MS/MS and ligand-binding assays (ELISA, MSD), as well as qPCR for gene therapy applications. Our capabilities cover pharmacokinetics (PK), immunogenicity (ADA/NAb), pharmacodynamics (PD), and biomarker analysis.

With extensive experience in regulated environments (GLP, GCP) and a strong focus on scientific rigor, project management, and client communication, Anapharm acts as a reliable partner for complex bioanalytical challenges.

Barcelona Clinical Coordinating Center (BCCC) is a trusted non-profit CRO (Contract Research Organization) supporting startups, biotech, medtech & pharmaceutical companies with end-to-end clinical trial execution, post-authorization studies, and expert consulting in regulatory affairs, statistics, and centralized image analysis.

CEREMET is an academic CRO for biomedicine and healthcare companies offering quality customer-focused services in compliance with the ISO 9001:2015 certificate and the Good Laboratory Principles.

Our services range from scientific consultancy to the execution of studies, including animal models and biomolecule analyses during product development. 

In vivo services include non-clinical studies of test substance and specimen drawing under GLP compliance.

The cornerstone of CEREMET’s activity is our flexibility, which allows us to adapt to each client’s workflow requirements and achieve highly satisfied customers.

Since 2025 CEREMET is member of the TECNIO label driven by the ACCIO agency from Generalitat de Catalunya to promote tech transfer activities.

The Comparative Medicine and Bioimage Centre of Catalonia (CMCiB) is a unique research centre designed to transform the medicine of the future, supporting biomedical innovation and preclinical research studies.

CMCiB's state-of-the-art facilities and collaborations with the scientific community and partner companies enable cutting-edge research in biomedicine in different stages of development, utilizing various animal models and bioimaging techniques, targeting research on radiomics and artificial intelligence to unravel and understand complex medical issues.

We are experts in medical device preclinical validation, non-GLP and GLP ensuring the latter meet regulatory standards for human use. The centre has been instrumental in the rigorous testing and validation of innovative tecnologies and products that are currently in clinical trials and are bound to improve patients’ lives.  

Services: 

• Medical device validation
• GLP studies
• Rodent models in biocontainment facility (oncology, immunology, cardiology studies, etc.)
• Rodent and Drosophila models on Biosafety level-3 facilities (studies with pathogens and viruses)
• Advanced Surgical facilities (swine/sheep models)
• Bioimaging- Image acquisition and processing (MRI, Radiovascular Intervention room, bioluminiscence and fluorescence)
• Highly equipped surgical rooms for living labs/surgical trainings

• We accelerate the discovery and development of life-changing medicines by focusing on scientific excellence coupled with deep disease understanding and proprietary next-gen technology platforms.

Franklyn Health is a full-service CRO dedicated to supporting clinical studies for medical device and in vitro diagnostics innovators. We are headquartered in the UK, with an office in Barcelona (ES) and Aarhus (DK). We support studies in the EU and the UK, but also have broad experience in the US and Australia/New Zealand. We provide clinical study support and can support regulatory strategy as well.

Merck Life Science, a division of Merck KGaA, partnes with researchers and manufacturers to enable scientific breakthroughs. 
We provide innovative bioprocess, lab, and analytical solutions, enabling efficient workflows, reliable quality, and accelerated timelines. Our portfolio spans cell culture, chromatography, lab essentials, and digital tools, backed by global support.